Management  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
the  ||| S:14 E:18 ||| DT
heartbeating  ||| S:18 E:31 ||| JJ
brain-dead  ||| S:31 E:42 ||| JJ
organ  ||| S:42 E:48 ||| NN
donor  ||| S:48 E:54 ||| VBD
The  ||| S:54 E:58 ||| DT
main  ||| S:58 E:63 ||| JJ
factor  ||| S:63 E:70 ||| NN
limiting  ||| S:70 E:79 ||| VBG
organ  ||| S:79 E:85 ||| JJ
donation  ||| S:85 E:94 ||| NN
is  ||| S:94 E:97 ||| VBZ
the  ||| S:97 E:101 ||| DT
availability  ||| S:101 E:114 ||| NN
of  ||| S:114 E:117 ||| IN
suitable  ||| S:117 E:126 ||| JJ
donors  ||| S:126 E:133 ||| NNS
and  ||| S:133 E:137 ||| CC
organs ||| S:137 E:143 ||| NNS
.  ||| S:143 E:145 ||| .
Currently ||| S:145 E:154 ||| RB
,  ||| S:154 E:156 ||| ,
most  ||| S:156 E:161 ||| JJS
transplants  ||| S:161 E:173 ||| NNS
follow  ||| S:173 E:180 ||| VBP
multiple  ||| S:180 E:189 ||| JJ
organ  ||| S:189 E:195 ||| NN
retrieval  ||| S:195 E:205 ||| NN
from  ||| S:205 E:210 ||| IN
heartbeating  ||| S:210 E:223 ||| JJ
brain-dead  ||| S:223 E:234 ||| JJ
organ  ||| S:234 E:240 ||| NN
donors ||| S:240 E:246 ||| NNS
.  ||| S:246 E:248 ||| .
However ||| S:248 E:255 ||| RB
,  ||| S:255 E:257 ||| ,
brain  ||| S:257 E:263 ||| NN
death  ||| S:263 E:269 ||| NN
is  ||| S:269 E:272 ||| VBZ
often  ||| S:272 E:278 ||| RB
associated  ||| S:278 E:289 ||| VBN
with  ||| S:289 E:294 ||| IN
marked  ||| S:294 E:301 ||| JJ
physiological  ||| S:301 E:315 ||| JJ
instability ||| S:315 E:326 ||| NN
,  ||| S:326 E:328 ||| ,
which ||| S:328 E:333 ||| WDT
,  ||| S:333 E:335 ||| ,
if  ||| S:335 E:338 ||| IN
not  ||| S:338 E:342 ||| RB
managed ||| S:342 E:349 ||| VBN
,  ||| S:349 E:351 ||| ,
can  ||| S:351 E:355 ||| MD
lead  ||| S:355 E:360 ||| VB
to  ||| S:360 E:363 ||| TO
deterioration  ||| S:363 E:377 ||| NN
in  ||| S:377 E:380 ||| IN
organ  ||| S:380 E:386 ||| JJ
function  ||| S:386 E:395 ||| NN
before  ||| S:395 E:402 ||| IN
retrieval ||| S:402 E:411 ||| NN
.  ||| S:411 E:413 ||| .
In  ||| S:413 E:416 ||| IN
some  ||| S:416 E:421 ||| DT
cases ||| S:421 E:426 ||| NNS
,  ||| S:426 E:428 ||| ,
this  ||| S:428 E:433 ||| DT
prevents  ||| S:433 E:442 ||| VBZ
successful  ||| S:442 E:453 ||| JJ
donation ||| S:453 E:461 ||| NN
.  ||| S:461 E:463 ||| .
There  ||| S:463 E:469 ||| EX
is  ||| S:469 E:472 ||| VBZ
increasing  ||| S:472 E:483 ||| VBG
evidence  ||| S:483 E:492 ||| NN
that  ||| S:492 E:497 ||| IN
moderation  ||| S:497 E:508 ||| NN
of  ||| S:508 E:511 ||| IN
these  ||| S:511 E:517 ||| DT
pathophysiological  ||| S:517 E:536 ||| JJ
changes  ||| S:536 E:544 ||| NNS
by  ||| S:544 E:547 ||| IN
active  ||| S:547 E:554 ||| JJ
management  ||| S:554 E:565 ||| NN
in  ||| S:565 E:568 ||| IN
Intensive  ||| S:568 E:578 ||| NNP
Care  ||| S:578 E:583 ||| NNP
maintains  ||| S:583 E:593 ||| VBZ
organ  ||| S:593 E:599 ||| JJ
function ||| S:599 E:607 ||| NN
,  ||| S:607 E:609 ||| ,
thereby  ||| S:609 E:617 ||| RB
increasing  ||| S:617 E:628 ||| VBG
the  ||| S:628 E:632 ||| DT
number  ||| S:632 E:639 ||| NN
and  ||| S:639 E:643 ||| CC
functional  ||| S:643 E:654 ||| JJ
quality  ||| S:654 E:662 ||| NN
of  ||| S:662 E:665 ||| IN
organs  ||| S:665 E:672 ||| JJ
available  ||| S:672 E:682 ||| JJ
for  ||| S:682 E:686 ||| IN
transplantation ||| S:686 E:701 ||| NN
.  ||| S:701 E:703 ||| .
This  ||| S:703 E:708 ||| DT
strategy  ||| S:708 E:717 ||| NN
of  ||| S:717 E:720 ||| IN
active  ||| S:720 E:727 ||| JJ
donor  ||| S:727 E:733 ||| NN
management  ||| S:733 E:744 ||| NN
requires  ||| S:744 E:753 ||| VBZ
an  ||| S:753 E:756 ||| DT
alteration  ||| S:756 E:767 ||| NN
of  ||| S:767 E:770 ||| IN
philosophy  ||| S:770 E:781 ||| NN
and  ||| S:781 E:785 ||| CC
therapy  ||| S:785 E:793 ||| NN
on  ||| S:793 E:796 ||| IN
the  ||| S:796 E:800 ||| DT
part  ||| S:800 E:805 ||| NN
of  ||| S:805 E:808 ||| IN
the  ||| S:808 E:812 ||| DT
intensive  ||| S:812 E:822 ||| JJ
care  ||| S:822 E:827 ||| NN
unit  ||| S:827 E:832 ||| NN
clinicians  ||| S:832 E:843 ||| NNS
and  ||| S:843 E:847 ||| CC
has  ||| S:847 E:851 ||| VBZ
significant  ||| S:851 E:863 ||| JJ
resource  ||| S:863 E:872 ||| NN
implications  ||| S:872 E:885 ||| NNS
if  ||| S:885 E:888 ||| IN
it  ||| S:888 E:891 ||| PRP
is  ||| S:891 E:894 ||| VBZ
to  ||| S:894 E:897 ||| TO
be  ||| S:897 E:900 ||| VB
delivered  ||| S:900 E:910 ||| VBN
reliably  ||| S:910 E:919 ||| RB
and  ||| S:919 E:923 ||| CC
safely ||| S:923 E:929 ||| RB
.  ||| S:929 E:931 ||| .
Despite  ||| S:931 E:939 ||| IN
increasing  ||| S:939 E:950 ||| VBG
consensus  ||| S:950 E:960 ||| NN
over  ||| S:960 E:965 ||| IN
donor  ||| S:965 E:971 ||| JJ
management  ||| S:971 E:982 ||| NN
protocols ||| S:982 E:991 ||| NNS
,  ||| S:991 E:993 ||| ,
many  ||| S:993 E:998 ||| JJ
of  ||| S:998 E:1001 ||| IN
their  ||| S:1001 E:1007 ||| PRP$
components  ||| S:1007 E:1018 ||| NNS
have  ||| S:1018 E:1023 ||| VBP
not  ||| S:1023 E:1027 ||| RB
yet  ||| S:1027 E:1031 ||| RB
been  ||| S:1031 E:1036 ||| VBN
subjected  ||| S:1036 E:1046 ||| VBN
to  ||| S:1046 E:1049 ||| TO
controlled  ||| S:1049 E:1060 ||| JJ
evaluation ||| S:1060 E:1070 ||| NN
.  ||| S:1070 E:1072 ||| .
Hence  ||| S:1072 E:1078 ||| RB
the  ||| S:1078 E:1082 ||| DT
optimal  ||| S:1082 E:1090 ||| JJ
combinations  ||| S:1090 E:1103 ||| NNS
of  ||| S:1103 E:1106 ||| IN
treatment  ||| S:1106 E:1116 ||| NN
goals ||| S:1116 E:1121 ||| NNS
,  ||| S:1121 E:1123 ||| ,
monitoring ||| S:1123 E:1133 ||| NN
,  ||| S:1133 E:1135 ||| ,
and  ||| S:1135 E:1139 ||| CC
specific  ||| S:1139 E:1148 ||| JJ
therapies  ||| S:1148 E:1158 ||| NNS
have  ||| S:1158 E:1163 ||| VBP
not  ||| S:1163 E:1167 ||| RB
yet  ||| S:1167 E:1171 ||| RB
been  ||| S:1171 E:1176 ||| VBN
fully  ||| S:1176 E:1182 ||| RB
defined ||| S:1182 E:1189 ||| VBN
.  ||| S:1189 E:1191 ||| .
More  ||| S:1191 E:1196 ||| JJR
research  ||| S:1196 E:1205 ||| NN
into  ||| S:1205 E:1210 ||| IN
the  ||| S:1210 E:1214 ||| DT
component  ||| S:1214 E:1224 ||| NN
techniques  ||| S:1224 E:1235 ||| NNS
is  ||| S:1235 E:1238 ||| VBZ
needed ||| S:1238 E:1244 ||| VBN
.  ||| S:1244 E:1246 ||| .
